1562333-92-9

1562333-92-9 structure

Name: Nvs-sm2
Chemical Name: NVS-SM2
CAS Number: 1562333-92-9
Molecular Formula: C₂₃H₃₀N₆O
Molecular Weight: 406.52
Catalog: Signaling Pathways Cell Cycle/DNA Damage DNA/RNA Synthesis
Create Date: 2021-09-14 18:01:29
Modify Date: 2024-01-14 17:19:24
NVS-SM2 is a potent, orally active and brain-penetrant SMN2 splicing enhancer with an EC50 of 2 nM for SMN. NVS-SM2 enhances U1-pre-mRNA association. NVS-SM2 promotes exon 7 inclusion and restores normal survival motor neuron (SMN) protein expression. NVS-SM2 can be used for spinal muscular atrophy (SMA) research[1][2].

Name	NVS-SM2

Description	NVS-SM2 is a potent, orally active and brain-penetrant SMN2 splicing enhancer with an EC50 of 2 nM for SMN. NVS-SM2 enhances U1-pre-mRNA association. NVS-SM2 promotes exon 7 inclusion and restores normal survival motor neuron (SMN) protein expression. NVS-SM2 can be used for spinal muscular atrophy (SMA) research[1][2].
Related Catalog	Signaling Pathways >> Cell Cycle/DNA Damage >> DNA/RNA Synthesis Research Areas >> Neurological Disease
Target	EC50: 5 nM (SMN)[1]
In Vitro	For NVS-SM2, the molecular mechanism of action is via stabilization of the transient double-strand RNA structure formed by the SMN2 pre-mRNA and U1 small nuclear ribonucleic protein (snRNP) complex. The binding affinity of U1 snRNP to the 5' splice site is increased in a sequence-selective manner, discrete from constitutive recognition[1].
In Vivo	NVS-SM2 (0.1-1 mg/kg; s.c.; for 30 days) treatment extends survival in a severe SMA mouse model[2]. Pharmacokinetic analysis demonstrate that NVS-SM2 is readily available in the brain after IV and oral (PO) administration in mouse and rat with Tmax of 3 h after PO with 3 mg/kg in mice, and treatment induced a 1.5-fold increase in SMN protein levels in the mouse brain[1]. Animal Model: Severe SMA mice[2] Dosage: 0.1 mg/kg and 1 mg/kg Administration: Subcutaneous injection; daily from day 2 to day 15, followed by every other day until day 30 Result: Extended survival in a severe SMA mouse model.
References	[1]. James Palacino, et al. SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice. Nat Chem Biol. 2015 Jul;11(7):511-7. [2]. Anne Rietz, et al. Short-duration splice promoting compound enables a tunable mouse model of spinal muscular atrophy. Life Sci Alliance. 2020 Nov 24;4(1):e202000889.

Molecular Formula	C₂₃H₃₀N₆O
Molecular Weight	406.52

1562333-92-9	1639115-52-8
1207258-55-6	2250019-95-3
1992047-61-6	1783816-74-9
2662454-54-6	941580-60-5
2349367-89-9	1158522-08-7
940364-43-2	134104-43-1
1355193-73-5	1044941-57-2
1713639-28-1	131615-57-1
6906-52-1	1160846-21-8
930439-75-1